Goldpac Group (HKG:3315) expects 7.6 million yuan in attributable profit for the first four months of 2026, a decrease of nearly 59% from the 18.4 million yuan recorded a year earlier, according to a filing with the Hong Kong bourse Monday.
The secure payment products provider's shares fell nearly 4% in morning trade Tuesday.
The firm attributed the decrease to intensified marketing competition and foreign exchange losses.
Singapore's High Court has criticized the manner in which United Overseas Bank (SGX:U11) has been taking inconsistent legal positions on late payment charges in connection with mortgage cases, according to a Straits Times report on Tuesday.Assistant Registrar, Randeep Singh Koonar, termed the bank's actions "unsatisfactory" for withdrawing claims in court when asked for a legal justification, the report said.The recent judgment was delivered in a 2026 case filed by UOB against a company named SGmade Co-Operates, that owed it around SG$556,200, the report noted.According to Randeep, the bank had withdrawn its claims when the High Court asked for legal justification, the report added.Later on, the bank admitted that it was not legally allowed to impose late payment charges via monthly installments, the report noted.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Here are the ASX-listed companies with the biggest losses on Tuesday.ASX (ASX:ASX): -12%, AU$51.51Elevra (ASX:ELV): -7%, AU$12.75PEXA Group (ASX:PXA): -7%, AU$10.67Infratil (ASX:IFT): -5%, AU$12.29Yancoal Australia (ASX:YAL): -4%, AU$6.69Telix Pharmaceuticals (ASX:TLX): -4%, AU$12.82Challenger (ASX:CGF): -4%, AU$8.89Whitehaven Coal (ASX:WHC): -4%, AU$8.51Netwealth Group (ASX:NWL): -3%, AU$21.69Paladin Energy (ASX:PDN): -3%, AU$11.13
Fisher & Paykel Healthcare's (ASX:FPH, NZE:FPH) result was in line with Jefferies' forecasts for revenue, and 2% above net profit after tax, with a higher-than-expected earnings before interest and tax margin, Jefferies said in a Tuesday note.Fisher & Paykel reported fiscal year 2026 underlying earnings of NZ$0.793 per share, up from NZ$0.639 a year earlier. Operating revenue for the 12 months ended March 31 was NZ$2.31 billion, compared with NZ$2.02 billion a year earlier.Jefferies forecasted net profit of NZ$459 million and sales revenue of NZ$2.3 billion. The firm reported higher-than-expected revenue in the hospital segment and lower-than-expected revenue in homecare.The investment firm retained its buy rating on Fisher & Paykel Healthcare and its price targets of AU$33.50 per share and NZ$41 per share.